• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1002

Bifidobacterium breve strain MCC1274

Intended Use: Intended for use as an ingredient in conventional foods including baked goods, breakfast cereals, fruit juices and nectars, fruit ices, vegetable juices, milk-based drinks and powders, yogurt, dairy product analogs, frozen dairy desserts, cheeses, condiments and spreads, nut and peanut spreads, gelatins and puddings, milk and non-milk meal replacements, and soft and hard candies and snack foods at a maximum level of 5 x 1010 colony forming units (CFU)/serving.
Basis: Scientific procedures
Notifier: Morinaga Milk Industry Co., Ltd.
Notifier Address: 33-1, Shiba 5-Chome, Minato-ku
Tokyo 108-8384
GRAS Notice (releasable information): GRN 1002 with amendments (in PDF) (3.6 MB)
Date of closure: Jul 22, 2022
FDA's Letter: FDA has no questions (in PDF) (221 kB)